GO Type |
GO Category |
GO Term |
No. of Plants |
No. of Medicinal Plants |
No. of Food Plants |
No. of Human Edible Plants |
No. of Agricultural Plants |
No. of Garden Plants |
BP |
GO:0008283;cell proliferation |
GO:0008284;positive regulation of cell proliferation
|
535 |
287 |
21 |
168 |
0 |
14 |
BP |
GO:0008152;metabolic process |
GO:0055114;oxidation-reduction process
|
963 |
465 |
23 |
299 |
1 |
27 |
BP |
GO:0008152;metabolic process |
GO:0097267;omega-hydroxylase P450 pathway
|
1962 |
920 |
74 |
560 |
1 |
38 |
BP |
GO:0008152;metabolic process |
GO:0046777;protein autophosphorylation
|
946 |
455 |
21 |
282 |
0 |
25 |
BP |
GO:0008152;metabolic process |
GO:0006703;estrogen biosynthetic process
|
188 |
103 |
9 |
66 |
0 |
6 |
BP |
GO:0008152;metabolic process |
GO:0019373;epoxygenase P450 pathway
|
1914 |
909 |
73 |
539 |
1 |
38 |
BP |
GO:0008152;metabolic process |
GO:0009404;toxin metabolic process
|
1664 |
783 |
59 |
467 |
1 |
33 |
BP |
GO:0032502;developmental process |
GO:0031100;animal organ regeneration
|
527 |
269 |
20 |
169 |
0 |
9 |
BP |
GO:0040011;locomotion |
GO:0030335;positive regulation of cell migration
|
270 |
130 |
8 |
73 |
0 |
7 |
BP |
GO:0008152;metabolic process |
GO:0018108;peptidyl-tyrosine phosphorylation
|
976 |
458 |
18 |
283 |
0 |
21 |
BP |
GO:0002376;immune system process |
GO:0030097;hemopoiesis
|
82 |
35 |
1 |
22 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0018894;dibenzo-p-dioxin metabolic process
|
1651 |
780 |
59 |
468 |
1 |
32 |
BP |
GO:0008152;metabolic process |
GO:0006730;one-carbon metabolic process
|
2564 |
1254 |
93 |
750 |
3 |
65 |
BP |
GO:0008152;metabolic process |
GO:0008610;lipid biosynthetic process
|
200 |
101 |
7 |
63 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:2001300;lipoxin metabolic process
|
315 |
160 |
11 |
96 |
0 |
6 |
BP |
GO:0032502;developmental process |
GO:0007568;aging
|
791 |
369 |
24 |
229 |
0 |
16 |
BP |
GO:0065007;biological regulation |
GO:0048872;homeostasis of number of cells
|
250 |
113 |
9 |
69 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0051897;positive regulation of protein kinase B signaling
|
396 |
200 |
18 |
122 |
0 |
6 |
BP |
GO:0008152;metabolic process |
GO:0038083;peptidyl-tyrosine autophosphorylation
|
370 |
178 |
16 |
104 |
0 |
6 |
BP |
GO:0050896;response to stimulus |
GO:0009611;response to wounding
|
216 |
117 |
12 |
68 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0070301;cellular response to hydrogen peroxide
|
544 |
282 |
20 |
176 |
0 |
14 |
BP |
Unclassified; |
GO:2000021;regulation of ion homeostasis
|
256 |
143 |
14 |
82 |
0 |
8 |
BP |
GO:0051179;localization |
GO:2001225;regulation of chloride transport
|
357 |
156 |
10 |
99 |
1 |
6 |
BP |
GO:0040011;locomotion |
GO:0014911;positive regulation of smooth muscle cell migration
|
55 |
28 |
2 |
17 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0015701;bicarbonate transport
|
2446 |
1194 |
89 |
713 |
3 |
58 |
BP |
GO:0009987;cellular process |
GO:0006286;base-excision repair, base-free sugar-phosphate removal
|
653 |
342 |
30 |
200 |
0 |
18 |
BP |
GO:0048511;rhythmic process |
GO:0048511;rhythmic process
|
153 |
64 |
7 |
49 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0045740;positive regulation of DNA replication
|
285 |
134 |
11 |
90 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:0046686;response to cadmium ion
|
115 |
47 |
2 |
31 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0070988;demethylation
|
227 |
109 |
9 |
71 |
0 |
6 |
BP |
GO:0009987;cellular process |
GO:0032849;positive regulation of cellular pH reduction
|
1671 |
819 |
67 |
487 |
1 |
37 |
BP |
GO:0009987;cellular process |
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling
|
70 |
40 |
1 |
30 |
0 |
1 |
BP |
GO:0022610;biological adhesion |
GO:0051894;positive regulation of focal adhesion assembly
|
285 |
145 |
12 |
90 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0071363;cellular response to growth factor stimulus
|
254 |
121 |
6 |
77 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:0048661;positive regulation of smooth muscle cell proliferation
|
75 |
38 |
0 |
23 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0046427;positive regulation of JAK-STAT cascade
|
63 |
35 |
0 |
28 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0045766;positive regulation of angiogenesis
|
126 |
69 |
6 |
49 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0030307;positive regulation of cell growth
|
27 |
15 |
1 |
9 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity
|
167 |
90 |
5 |
61 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0043406;positive regulation of MAP kinase activity
|
168 |
89 |
7 |
58 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:2000352;negative regulation of endothelial cell apoptotic process
|
36 |
20 |
0 |
12 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0046718;viral entry into host cell
|
189 |
89 |
6 |
65 |
0 |
6 |
BP |
GO:0009987;cellular process |
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
42 |
25 |
1 |
14 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051902;negative regulation of mitochondrial depolarization
|
38 |
22 |
2 |
11 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0002009;morphogenesis of an epithelium
|
131 |
65 |
4 |
50 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle
|
49 |
23 |
0 |
14 |
0 |
1 |
BP |
Unclassified; |
GO:0006461;protein complex assembly
|
58 |
34 |
3 |
18 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0051591;response to cAMP
|
77 |
33 |
2 |
20 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0042307;positive regulation of protein import into nucleus
|
85 |
39 |
0 |
31 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0045930;negative regulation of mitotic cell cycle
|
23 |
11 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903243;negative regulation of cardiac muscle hypertrophy in response to stress
|
217 |
102 |
5 |
66 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0007435;salivary gland morphogenesis
|
282 |
128 |
5 |
78 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0043066;negative regulation of apoptotic process
|
834 |
383 |
19 |
236 |
0 |
22 |
BP |
GO:0009987;cellular process |
GO:0035690;cellular response to drug
|
152 |
67 |
6 |
30 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway
|
105 |
52 |
4 |
28 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0034614;cellular response to reactive oxygen species
|
159 |
73 |
6 |
37 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0097237;cellular response to toxic substance
|
59 |
23 |
3 |
11 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0045429;positive regulation of nitric oxide biosynthetic process
|
189 |
85 |
7 |
48 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0071310;cellular response to organic substance
|
160 |
77 |
8 |
37 |
1 |
8 |
BP |
GO:0065007;biological regulation |
GO:0010817;regulation of hormone levels
|
139 |
67 |
11 |
36 |
0 |
4 |
BP |
GO:0065007;biological regulation |
GO:0055081;anion homeostasis
|
13 |
11 |
2 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0071248;cellular response to metal ion
|
7 |
5 |
1 |
3 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0042593;glucose homeostasis
|
21 |
13 |
2 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033993;response to lipid
|
302 |
165 |
14 |
107 |
0 |
9 |
BP |
GO:0008152;metabolic process |
GO:0016098;monoterpenoid metabolic process
|
1256 |
594 |
36 |
347 |
0 |
13 |
BP |
GO:0050896;response to stimulus |
GO:0042738;exogenous drug catabolic process
|
557 |
269 |
21 |
145 |
0 |
5 |
BP |
GO:0050896;response to stimulus |
GO:0009725;response to hormone
|
237 |
121 |
8 |
72 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0070213;protein auto-ADP-ribosylation
|
69 |
41 |
5 |
23 |
1 |
2 |
BP |
GO:0008152;metabolic process |
GO:0022900;electron transport chain
|
108 |
41 |
2 |
27 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0007210;serotonin receptor signaling pathway
|
112 |
60 |
10 |
35 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0071880;adenylate cyclase-activating adrenergic receptor signaling pathway
|
46 |
28 |
5 |
12 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007198;adenylate cyclase-inhibiting serotonin receptor signaling pathway
|
98 |
47 |
3 |
31 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0002031;G-protein coupled receptor internalization
|
49 |
22 |
1 |
13 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0010513;positive regulation of phosphatidylinositol biosynthetic process
|
44 |
28 |
8 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0014059;regulation of dopamine secretion
|
43 |
16 |
2 |
10 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0007194;negative regulation of adenylate cyclase activity
|
45 |
21 |
2 |
13 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0070374;positive regulation of ERK1 and ERK2 cascade
|
293 |
162 |
16 |
91 |
0 |
7 |
BP |
GO:0051179;localization |
GO:0051209;release of sequestered calcium ion into cytosol
|
37 |
18 |
2 |
7 |
0 |
2 |
BP |
GO:0023052;signaling |
GO:0051967;negative regulation of synaptic transmission, glutamatergic
|
43 |
20 |
1 |
10 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007208;phospholipase C-activating serotonin receptor signaling pathway
|
41 |
27 |
8 |
10 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0048148;behavioral response to cocaine
|
57 |
27 |
3 |
15 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0007202;activation of phospholipase C activity
|
23 |
9 |
2 |
4 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0032098;regulation of appetite
|
19 |
6 |
0 |
3 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0007626;locomotory behavior
|
32 |
14 |
0 |
9 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0002032;desensitization of G-protein coupled receptor protein signaling pathway by arrestin
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0060160;negative regulation of dopamine receptor signaling pathway
|
50 |
23 |
1 |
14 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0002025;norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure
|
20 |
8 |
2 |
3 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0042755;eating behavior
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0035625;epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway
|
214 |
102 |
10 |
52 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0001994;norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure
|
20 |
8 |
1 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0032811;negative regulation of epinephrine secretion
|
215 |
103 |
10 |
53 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0014827;intestine smooth muscle contraction
|
24 |
11 |
0 |
5 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0043278;response to morphine
|
43 |
13 |
1 |
9 |
0 |
2 |
BP |
GO:0023052;signaling |
GO:0032228;regulation of synaptic transmission, GABAergic
|
34 |
21 |
2 |
12 |
0 |
2 |
BP |
Unclassified; |
GO:0045907;positive regulation of vasoconstriction
|
24 |
12 |
3 |
5 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0071312;cellular response to alkaloid
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0045987;positive regulation of smooth muscle contraction
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0040011;locomotion |
GO:0090325;regulation of locomotion involved in locomotory behavior
|
49 |
23 |
1 |
14 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0071502;cellular response to temperature stimulus
|
23 |
11 |
1 |
5 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0007190;activation of adenylate cyclase activity
|
34 |
12 |
2 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0050709;negative regulation of protein secretion
|
37 |
13 |
1 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0014062;regulation of serotonin secretion
|
22 |
9 |
1 |
4 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0008542;visual learning
|
68 |
35 |
2 |
18 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0038003;opioid receptor signaling pathway
|
21 |
7 |
0 |
3 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0031649;heat generation
|
20 |
8 |
2 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0010700;negative regulation of norepinephrine secretion
|
84 |
44 |
5 |
23 |
0 |
2 |
BP |
GO:0023052;signaling |
GO:0051584;regulation of dopamine uptake involved in synaptic transmission
|
56 |
29 |
2 |
13 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0032922;circadian regulation of gene expression
|
67 |
25 |
2 |
19 |
0 |
5 |
BP |
GO:0032501;multicellular organismal process |
GO:0002024;diet induced thermogenesis
|
19 |
7 |
2 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007191;adenylate cyclase-activating dopamine receptor signaling pathway
|
39 |
15 |
0 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007195;adenylate cyclase-inhibiting dopamine receptor signaling pathway
|
45 |
19 |
1 |
12 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0034776;response to histamine
|
44 |
19 |
1 |
12 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0040015;negative regulation of multicellular organism growth
|
17 |
6 |
2 |
2 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0043401;steroid hormone mediated signaling pathway
|
207 |
101 |
5 |
64 |
1 |
4 |
BP |
GO:0008152;metabolic process |
GO:0006367;transcription initiation from RNA polymerase II promoter
|
209 |
111 |
9 |
69 |
1 |
4 |
BP |
GO:0009987;cellular process |
GO:0030522;intracellular receptor signaling pathway
|
252 |
123 |
9 |
78 |
1 |
5 |
BP |
Unclassified; |
GO:0044259;multicellular organismal macromolecule metabolic process
|
193 |
120 |
15 |
64 |
0 |
5 |
BP |
Unclassified; |
GO:0044236;multicellular organism metabolic process
|
190 |
117 |
14 |
62 |
0 |
6 |
BP |
GO:0008152;metabolic process |
GO:0030574;collagen catabolic process
|
172 |
103 |
10 |
55 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0022617;extracellular matrix disassembly
|
146 |
84 |
7 |
45 |
0 |
3 |
BP |
GO:0032502;developmental process |
GO:0048513;animal organ development
|
130 |
62 |
5 |
35 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0051289;protein homotetramerization
|
17 |
11 |
2 |
6 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0010035;response to inorganic substance
|
349 |
158 |
8 |
94 |
0 |
11 |
BP |
GO:0009987;cellular process |
GO:0001973;adenosine receptor signaling pathway
|
224 |
134 |
10 |
78 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:0001666;response to hypoxia
|
296 |
174 |
18 |
108 |
0 |
11 |
BP |
GO:0008283;cell proliferation |
GO:0008285;negative regulation of cell proliferation
|
79 |
41 |
1 |
21 |
0 |
3 |
BP |
GO:0023052;signaling |
GO:0032230;positive regulation of synaptic transmission, GABAergic
|
264 |
121 |
9 |
74 |
0 |
4 |
BP |
GO:0065007;biological regulation |
GO:0048878;chemical homeostasis
|
335 |
162 |
10 |
94 |
1 |
9 |
BP |
GO:0050896;response to stimulus |
GO:0071498;cellular response to fluid shear stress
|
21 |
13 |
2 |
6 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0051968;positive regulation of synaptic transmission, glutamatergic
|
19 |
11 |
0 |
7 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0017144;drug metabolic process
|
163 |
84 |
6 |
57 |
0 |
6 |
BP |
GO:0050896;response to stimulus |
GO:0014074;response to purine-containing compound
|
37 |
20 |
1 |
12 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0035295;tube development
|
17 |
9 |
0 |
5 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0043114;regulation of vascular permeability
|
21 |
13 |
1 |
7 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
20 |
12 |
0 |
7 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0050728;negative regulation of inflammatory response
|
308 |
156 |
15 |
97 |
0 |
7 |
BP |
GO:0009987;cellular process |
GO:0007569;cell aging
|
32 |
15 |
1 |
10 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0014070;response to organic cyclic compound
|
549 |
252 |
19 |
151 |
0 |
9 |
BP |
GO:0051179;localization |
GO:0051050;positive regulation of transport
|
45 |
27 |
3 |
14 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0010039;response to iron ion
|
27 |
14 |
1 |
12 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:2000648;positive regulation of stem cell proliferation
|
18 |
8 |
0 |
8 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0032787;monocarboxylic acid metabolic process
|
89 |
43 |
2 |
30 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0071456;cellular response to hypoxia
|
134 |
66 |
5 |
41 |
0 |
6 |
BP |
Unclassified; |
GO:0042310;vasoconstriction
|
82 |
44 |
7 |
28 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0001659;temperature homeostasis
|
20 |
7 |
1 |
7 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0097746;regulation of blood vessel diameter
|
94 |
55 |
8 |
31 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0009628;response to abiotic stimulus
|
58 |
26 |
2 |
14 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0021853;cerebral cortex GABAergic interneuron migration
|
58 |
34 |
1 |
20 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0050795;regulation of behavior
|
16 |
14 |
5 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0030432;peristalsis
|
34 |
16 |
0 |
11 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0018958;phenol-containing compound metabolic process
|
12 |
8 |
0 |
5 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021756;striatum development
|
32 |
14 |
0 |
10 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0045597;positive regulation of cell differentiation
|
6 |
5 |
1 |
3 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007625;grooming behavior
|
30 |
13 |
0 |
10 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071407;cellular response to organic cyclic compound
|
478 |
241 |
26 |
138 |
0 |
13 |
BP |
GO:0008152;metabolic process |
GO:0072593;reactive oxygen species metabolic process
|
74 |
37 |
2 |
26 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0001961;positive regulation of cytokine-mediated signaling pathway
|
128 |
66 |
8 |
42 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0050665;hydrogen peroxide biosynthetic process
|
442 |
181 |
9 |
126 |
1 |
4 |
BP |
GO:0009987;cellular process |
GO:0048010;vascular endothelial growth factor receptor signaling pathway
|
132 |
66 |
9 |
36 |
0 |
2 |
BP |
GO:0022610;biological adhesion |
GO:0051893;regulation of focal adhesion assembly
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007172;signal complex assembly
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0002376;immune system process |
GO:0002684;positive regulation of immune system process
|
39 |
17 |
1 |
10 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0060159;regulation of dopamine receptor signaling pathway
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0038127;ERBB signaling pathway
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0048608;reproductive structure development
|
33 |
13 |
2 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045595;regulation of cell differentiation
|
31 |
10 |
1 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0038166;angiotensin-activated signaling pathway
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling
|
41 |
21 |
3 |
8 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0030168;platelet activation
|
58 |
30 |
6 |
16 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2000811;negative regulation of anoikis
|
37 |
16 |
2 |
5 |
0 |
1 |
BP |
GO:0051179;localization |
GO:2000641;regulation of early endosome to late endosome transport
|
32 |
11 |
1 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0071222;cellular response to lipopolysaccharide
|
38 |
12 |
1 |
5 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0044597;daunorubicin metabolic process
|
58 |
32 |
2 |
15 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0044598;doxorubicin metabolic process
|
60 |
29 |
2 |
12 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032355;response to estradiol
|
60 |
23 |
2 |
12 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016125;sterol metabolic process
|
26 |
9 |
0 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009820;alkaloid metabolic process
|
246 |
112 |
7 |
59 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0009804;coumarin metabolic process
|
125 |
58 |
3 |
38 |
1 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0032496;response to lipopolysaccharide
|
270 |
121 |
10 |
70 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:0010243;response to organonitrogen compound
|
57 |
34 |
2 |
21 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902533;positive regulation of intracellular signal transduction
|
68 |
38 |
0 |
25 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0038171;cannabinoid signaling pathway
|
124 |
55 |
3 |
38 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0045471;response to ethanol
|
80 |
33 |
3 |
25 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0051262;protein tetramerization
|
47 |
27 |
5 |
16 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051001;negative regulation of nitric-oxide synthase activity
|
103 |
41 |
3 |
27 |
0 |
1 |
BP |
GO:0019740;nitrogen utilization |
GO:0006808;regulation of nitrogen utilization
|
107 |
52 |
6 |
26 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0051716;cellular response to stimulus
|
36 |
20 |
1 |
13 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:1901653;cellular response to peptide
|
170 |
84 |
4 |
51 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0002933;lipid hydroxylation
|
209 |
93 |
6 |
56 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0006954;inflammatory response
|
79 |
41 |
4 |
23 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0055082;cellular chemical homeostasis
|
73 |
34 |
6 |
18 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0014065;phosphatidylinositol 3-kinase signaling
|
92 |
47 |
6 |
28 |
0 |
1 |
BP |
GO:0040007;growth |
GO:0045927;positive regulation of growth
|
90 |
47 |
6 |
30 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0051495;positive regulation of cytoskeleton organization
|
90 |
50 |
3 |
31 |
0 |
2 |
BP |
GO:0022610;biological adhesion |
GO:0034446;substrate adhesion-dependent cell spreading
|
74 |
36 |
0 |
22 |
0 |
1 |
BP |
GO:0008283;cell proliferation |
GO:0042127;regulation of cell proliferation
|
129 |
66 |
2 |
42 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0006082;organic acid metabolic process
|
11 |
4 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010557;positive regulation of macromolecule biosynthetic process
|
52 |
29 |
5 |
13 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0031328;positive regulation of cellular biosynthetic process
|
19 |
16 |
4 |
5 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0006508;proteolysis
|
4 |
3 |
2 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071417;cellular response to organonitrogen compound
|
95 |
69 |
15 |
31 |
0 |
7 |
BP |
GO:0008152;metabolic process |
GO:0006805;xenobiotic metabolic process
|
273 |
142 |
13 |
73 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0019752;carboxylic acid metabolic process
|
7 |
6 |
2 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2000107;negative regulation of leukocyte apoptotic process
|
42 |
16 |
3 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:2001303;lipoxin A4 biosynthetic process
|
262 |
161 |
20 |
97 |
0 |
9 |
BP |
GO:0008152;metabolic process |
GO:0051122;hepoxilin biosynthetic process
|
218 |
138 |
18 |
79 |
0 |
6 |
BP |
GO:0009987;cellular process |
GO:1902751;positive regulation of cell cycle G2/M phase transition
|
8 |
7 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051090;regulation of DNA binding transcription factor activity
|
16 |
9 |
1 |
7 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0010575;positive regulation of vascular endothelial growth factor production
|
28 |
18 |
3 |
9 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0055093;response to hyperoxia
|
81 |
60 |
11 |
36 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0071345;cellular response to cytokine stimulus
|
19 |
15 |
4 |
7 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:1901992;positive regulation of mitotic cell cycle phase transition
|
30 |
13 |
0 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:2000045;regulation of G1/S transition of mitotic cell cycle
|
6 |
4 |
2 |
2 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0071276;cellular response to cadmium ion
|
78 |
51 |
8 |
29 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0030641;regulation of cellular pH
|
15 |
8 |
2 |
3 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0032148;activation of protein kinase B activity
|
29 |
24 |
4 |
10 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0008202;steroid metabolic process
|
632 |
271 |
24 |
166 |
0 |
7 |
BP |
GO:0022414;reproductive process |
GO:0001892;embryonic placenta development
|
47 |
21 |
2 |
10 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0009314;response to radiation
|
38 |
16 |
5 |
9 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:1903580;positive regulation of ATP metabolic process
|
73 |
35 |
3 |
24 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0009967;positive regulation of signal transduction
|
69 |
32 |
1 |
20 |
1 |
2 |
BP |
GO:0009987;cellular process |
GO:0033554;cellular response to stress
|
123 |
57 |
6 |
30 |
0 |
6 |
BP |
GO:0050896;response to stimulus |
GO:0042493;response to drug
|
102 |
42 |
3 |
24 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0006706;steroid catabolic process
|
169 |
77 |
3 |
48 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0008209;androgen metabolic process
|
92 |
41 |
3 |
27 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0097695;establishment of macromolecular complex localization to telomere
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0097694;establishment of RNA localization to telomere
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:1904884;positive regulation of telomerase catalytic core complex assembly
|
4 |
4 |
1 |
2 |
0 |
0 |
BP |
Unclassified; |
GO:0035428;hexose transmembrane transport
|
51 |
23 |
4 |
12 |
0 |
1 |
BP |
GO:0051179;localization |
GO:1904659;glucose transmembrane transport
|
51 |
23 |
4 |
12 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0051054;positive regulation of DNA metabolic process
|
29 |
12 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1902893;regulation of pri-miRNA transcription from RNA polymerase II promoter
|
55 |
32 |
3 |
24 |
1 |
4 |
BP |
GO:0050896;response to stimulus |
GO:1901652;response to peptide
|
32 |
21 |
6 |
8 |
1 |
4 |
BP |
GO:0009987;cellular process |
GO:0010638;positive regulation of organelle organization
|
52 |
31 |
4 |
15 |
1 |
4 |
BP |
GO:0008152;metabolic process |
GO:2000377;regulation of reactive oxygen species metabolic process
|
46 |
30 |
3 |
11 |
1 |
2 |
BP |
GO:0065007;biological regulation |
GO:0042592;homeostatic process
|
134 |
66 |
4 |
34 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0030198;extracellular matrix organization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0030260;entry into host cell
|
5 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019433;triglyceride catabolic process
|
324 |
182 |
28 |
105 |
0 |
9 |
BP |
GO:0051179;localization |
GO:0006909;phagocytosis
|
18 |
12 |
3 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0006950;response to stress
|
21 |
12 |
1 |
6 |
0 |
0 |
BP |
GO:0048511;rhythmic process |
GO:0042752;regulation of circadian rhythm
|
34 |
17 |
1 |
10 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0034599;cellular response to oxidative stress
|
26 |
12 |
0 |
12 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0030334;regulation of cell migration
|
69 |
30 |
1 |
25 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0019372;lipoxygenase pathway
|
108 |
64 |
7 |
39 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0043393;regulation of protein binding
|
12 |
9 |
1 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0032870;cellular response to hormone stimulus
|
36 |
16 |
1 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0010907;positive regulation of glucose metabolic process
|
56 |
28 |
3 |
23 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0001775;cell activation
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway
|
6 |
6 |
2 |
4 |
0 |
0 |
BP |
Unclassified; |
GO:0019229;regulation of vasoconstriction
|
9 |
9 |
2 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0044070;regulation of anion transport
|
21 |
6 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0006939;smooth muscle contraction
|
38 |
17 |
0 |
13 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0016488;farnesol catabolic process
|
12 |
5 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001252;positive regulation of chromosome organization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007610;behavior
|
31 |
16 |
1 |
13 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0090068;positive regulation of cell cycle process
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070989;oxidative demethylation
|
431 |
196 |
13 |
112 |
0 |
3 |
BP |
GO:0008283;cell proliferation |
GO:0008283;cell proliferation
|
36 |
17 |
3 |
9 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:1904707;positive regulation of vascular smooth muscle cell proliferation
|
58 |
45 |
12 |
24 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0071375;cellular response to peptide hormone stimulus
|
41 |
18 |
5 |
11 |
0 |
0 |
BP |
GO:0000003;reproduction |
GO:0022414;reproductive process
|
7 |
6 |
2 |
5 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0001503;ossification
|
25 |
24 |
8 |
11 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0010634;positive regulation of epithelial cell migration
|
9 |
7 |
2 |
6 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0023057;negative regulation of signaling
|
4 |
4 |
1 |
2 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0009888;tissue development
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051222;positive regulation of protein transport
|
26 |
15 |
0 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0071073;positive regulation of phospholipid biosynthetic process
|
49 |
18 |
1 |
10 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0018105;peptidyl-serine phosphorylation
|
46 |
20 |
0 |
15 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0018107;peptidyl-threonine phosphorylation
|
13 |
8 |
1 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043065;positive regulation of apoptotic process
|
32 |
19 |
2 |
11 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048731;system development
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0007498;mesoderm development
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0000186;activation of MAPKK activity
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0048015;phosphatidylinositol-mediated signaling
|
6 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010468;regulation of gene expression
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0080135;regulation of cellular response to stress
|
27 |
10 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0000187;activation of MAPK activity
|
11 |
6 |
0 |
5 |
0 |
0 |
BP |
Unclassified; |
GO:0007262;STAT protein import into nucleus
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0022610;biological adhesion |
GO:0045785;positive regulation of cell adhesion
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0002066;columnar/cuboidal epithelial cell development
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0010975;regulation of neuron projection development
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1904885;beta-catenin destruction complex assembly
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010543;regulation of platelet activation
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0010863;positive regulation of phospholipase C activity
|
7 |
4 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0097194;execution phase of apoptosis
|
52 |
18 |
0 |
16 |
0 |
1 |
BP |
GO:0022610;biological adhesion |
GO:0001952;regulation of cell-matrix adhesion
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902531;regulation of intracellular signal transduction
|
9 |
8 |
1 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046885;regulation of hormone biosynthetic process
|
11 |
4 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0061370;testosterone biosynthetic process
|
46 |
15 |
1 |
10 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0038084;vascular endothelial growth factor signaling pathway
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress
|
3 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060068;vagina development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0033160;positive regulation of protein import into nucleus, translocation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002522;leukocyte migration involved in immune response
|
9 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001028;positive regulation of endothelial cell chemotaxis
|
10 |
6 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0034097;response to cytokine
|
28 |
14 |
0 |
7 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051900;regulation of mitochondrial depolarization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0033138;positive regulation of peptidyl-serine phosphorylation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046854;phosphatidylinositol phosphorylation
|
6 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010508;positive regulation of autophagy
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070640;vitamin D3 metabolic process
|
3 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0014042;positive regulation of neuron maturation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0046620;regulation of organ growth
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001818;negative regulation of cytokine production
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0045088;regulation of innate immune response
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001235;positive regulation of apoptotic signaling pathway
|
8 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051726;regulation of cell cycle
|
17 |
5 |
0 |
3 |
0 |
0 |
BP |
Unclassified; |
GO:0097062;dendritic spine maintenance
|
71 |
31 |
1 |
16 |
0 |
0 |
BP |
Unclassified; |
GO:0035413;positive regulation of catenin import into nucleus
|
39 |
17 |
1 |
7 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0097242;amyloid-beta clearance
|
39 |
17 |
1 |
7 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006629;lipid metabolic process
|
40 |
11 |
0 |
10 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0016042;lipid catabolic process
|
69 |
34 |
1 |
28 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0048856;anatomical structure development
|
58 |
32 |
2 |
22 |
0 |
1 |
BP |
GO:0002376;immune system process |
GO:0010760;negative regulation of macrophage chemotaxis
|
50 |
18 |
0 |
15 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0035162;embryonic hemopoiesis
|
6 |
5 |
3 |
2 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0030154;cell differentiation
|
14 |
14 |
5 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032963;collagen metabolic process
|
12 |
10 |
5 |
5 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033273;response to vitamin
|
26 |
23 |
7 |
11 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007346;regulation of mitotic cell cycle
|
46 |
23 |
1 |
14 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0050714;positive regulation of protein secretion
|
58 |
38 |
5 |
30 |
0 |
3 |
BP |
GO:0032502;developmental process |
GO:0048732;gland development
|
17 |
11 |
1 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001819;positive regulation of cytokine production
|
10 |
10 |
2 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902905;positive regulation of supramolecular fiber organization
|
35 |
17 |
2 |
12 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:0050679;positive regulation of epithelial cell proliferation
|
38 |
22 |
1 |
18 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway
|
14 |
13 |
5 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048871;multicellular organismal homeostasis
|
18 |
8 |
1 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0030258;lipid modification
|
22 |
11 |
2 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031334;positive regulation of protein complex assembly
|
24 |
12 |
2 |
7 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0046486;glycerolipid metabolic process
|
4 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0035635;entry of bacterium into host cell
|
20 |
10 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007197;adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway
|
29 |
24 |
5 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0007207;phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway
|
29 |
24 |
5 |
8 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0007271;synaptic transmission, cholinergic
|
32 |
27 |
6 |
8 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0007399;nervous system development
|
28 |
19 |
2 |
10 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0040012;regulation of locomotion
|
3 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0051930;regulation of sensory perception of pain
|
35 |
14 |
2 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0043270;positive regulation of ion transport
|
12 |
8 |
1 |
6 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0045893;positive regulation of transcription, DNA-templated
|
39 |
22 |
2 |
17 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0030520;intracellular estrogen receptor signaling pathway
|
37 |
21 |
1 |
17 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:1901796;regulation of signal transduction by p53 class mediator
|
44 |
22 |
3 |
18 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0016101;diterpenoid metabolic process
|
57 |
24 |
1 |
23 |
0 |
2 |
BP |
GO:0051179;localization |
GO:0060341;regulation of cellular localization
|
49 |
23 |
1 |
19 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0006807;nitrogen compound metabolic process
|
10 |
6 |
0 |
1 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:1904355;positive regulation of telomere capping
|
11 |
9 |
2 |
5 |
0 |
1 |
BP |
GO:0008283;cell proliferation |
GO:0002052;positive regulation of neuroblast proliferation
|
5 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032212;positive regulation of telomere maintenance via telomerase
|
7 |
6 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019858;cytosine metabolic process
|
8 |
5 |
1 |
3 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007228;positive regulation of hh target transcription factor activity
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0003140;determination of left/right asymmetry in lateral mesoderm
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0021938;smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
36 |
10 |
1 |
11 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0040014;regulation of multicellular organism growth
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051100;negative regulation of binding
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0042149;cellular response to glucose starvation
|
20 |
5 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016241;regulation of macroautophagy
|
17 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0044281;small molecule metabolic process
|
16 |
11 |
1 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0019725;cellular homeostasis
|
4 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045859;regulation of protein kinase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0070542;response to fatty acid
|
113 |
55 |
5 |
32 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0043434;response to peptide hormone
|
44 |
22 |
3 |
11 |
0 |
1 |
BP |
Unclassified; |
GO:1990535;neuron projection maintenance
|
28 |
11 |
0 |
9 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0031663;lipopolysaccharide-mediated signaling pathway
|
5 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0060045;positive regulation of cardiac muscle cell proliferation
|
34 |
9 |
1 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0034605;cellular response to heat
|
32 |
14 |
0 |
5 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0034162;toll-like receptor 9 signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002758;innate immune response-activating signal transduction
|
10 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032088;negative regulation of NF-kappaB transcription factor activity
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071480;cellular response to gamma radiation
|
3 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050727;regulation of inflammatory response
|
20 |
8 |
0 |
8 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070372;regulation of ERK1 and ERK2 cascade
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0097028;dendritic cell differentiation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0050920;regulation of chemotaxis
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038128;ERBB2 signaling pathway
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071364;cellular response to epidermal growth factor stimulus
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000226;microtubule cytoskeleton organization
|
4 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0034641;cellular nitrogen compound metabolic process
|
6 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0001938;positive regulation of endothelial cell proliferation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016572;histone phosphorylation
|
37 |
16 |
2 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000379;positive regulation of reactive oxygen species metabolic process
|
31 |
14 |
1 |
6 |
0 |
1 |
BP |
GO:0040011;locomotion |
GO:0001667;ameboidal-type cell migration
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0009887;animal organ morphogenesis
|
12 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070228;regulation of lymphocyte apoptotic process
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035235;ionotropic glutamate receptor signaling pathway
|
36 |
23 |
3 |
15 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0060079;excitatory postsynaptic potential
|
40 |
27 |
3 |
16 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007196;adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway
|
19 |
14 |
3 |
9 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0051966;regulation of synaptic transmission, glutamatergic
|
16 |
12 |
2 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0010038;response to metal ion
|
84 |
43 |
5 |
25 |
0 |
1 |
BP |
GO:0022414;reproductive process |
GO:0007566;embryo implantation
|
10 |
8 |
0 |
4 |
0 |
1 |
BP |
Unclassified; |
GO:0003056;regulation of vascular smooth muscle contraction
|
20 |
15 |
3 |
5 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0050805;negative regulation of synaptic transmission
|
38 |
22 |
1 |
10 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0046541;saliva secretion
|
26 |
21 |
4 |
6 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0009115;xanthine catabolic process
|
16 |
6 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0035239;tube morphogenesis
|
7 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:2000194;regulation of female gonad development
|
7 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0046628;positive regulation of insulin receptor signaling pathway
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010564;regulation of cell cycle process
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901989;positive regulation of cell cycle phase transition
|
8 |
8 |
3 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:1902895;positive regulation of pri-miRNA transcription from RNA polymerase II promoter
|
24 |
10 |
3 |
7 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0043457;regulation of cellular respiration
|
5 |
5 |
3 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033280;response to vitamin D
|
4 |
4 |
2 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0060134;prepulse inhibition
|
37 |
18 |
0 |
15 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0001975;response to amphetamine
|
35 |
19 |
1 |
13 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0035815;positive regulation of renal sodium excretion
|
24 |
10 |
0 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0030817;regulation of cAMP biosynthetic process
|
5 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0043266;regulation of potassium ion transport
|
5 |
3 |
2 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0046883;regulation of hormone secretion
|
8 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0042321;negative regulation of circadian sleep/wake cycle, sleep
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045776;negative regulation of blood pressure
|
26 |
11 |
0 |
9 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0043271;negative regulation of ion transport
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0048167;regulation of synaptic plasticity
|
9 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019216;regulation of lipid metabolic process
|
8 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007416;synapse assembly
|
14 |
10 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060158;phospholipase C-activating dopamine receptor signaling pathway
|
28 |
12 |
0 |
10 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0035810;positive regulation of urine volume
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0014048;regulation of glutamate secretion
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009636;response to toxic substance
|
67 |
27 |
4 |
13 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0046677;response to antibiotic
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0023051;regulation of signaling
|
15 |
9 |
1 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009822;alkaloid catabolic process
|
261 |
134 |
10 |
66 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0045761;regulation of adenylate cyclase activity
|
37 |
17 |
4 |
11 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0034220;ion transmembrane transport
|
19 |
11 |
0 |
6 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0044242;cellular lipid catabolic process
|
4 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048143;astrocyte activation
|
50 |
19 |
0 |
19 |
0 |
4 |
BP |
GO:0023052;signaling |
GO:0046887;positive regulation of hormone secretion
|
10 |
9 |
1 |
8 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002682;regulation of immune system process
|
4 |
4 |
1 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0042060;wound healing
|
78 |
46 |
8 |
24 |
0 |
3 |
BP |
GO:0002376;immune system process |
GO:0045639;positive regulation of myeloid cell differentiation
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0030518;intracellular steroid hormone receptor signaling pathway
|
13 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060748;tertiary branching involved in mammary gland duct morphogenesis
|
14 |
7 |
1 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019369;arachidonic acid metabolic process
|
67 |
36 |
4 |
17 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0006691;leukotriene metabolic process
|
62 |
36 |
1 |
24 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0031116;positive regulation of microtubule polymerization
|
36 |
11 |
1 |
13 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0046688;response to copper ion
|
8 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0009653;anatomical structure morphogenesis
|
3 |
2 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019222;regulation of metabolic process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006915;apoptotic process
|
6 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0014910;regulation of smooth muscle cell migration
|
20 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1903409;reactive oxygen species biosynthetic process
|
10 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009266;response to temperature stimulus
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045600;positive regulation of fat cell differentiation
|
31 |
15 |
4 |
6 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0015721;bile acid and bile salt transport
|
102 |
37 |
2 |
32 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071280;cellular response to copper ion
|
30 |
9 |
0 |
11 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0002793;positive regulation of peptide secretion
|
13 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0000023;maltose metabolic process
|
35 |
14 |
1 |
11 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071320;cellular response to cAMP
|
5 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071396;cellular response to lipid
|
5 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0000122;negative regulation of transcription from RNA polymerase II promoter
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043433;negative regulation of DNA binding transcription factor activity
|
4 |
2 |
1 |
2 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0090277;positive regulation of peptide hormone secretion
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0070198;protein localization to chromosome, telomeric region
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010332;response to gamma radiation
|
18 |
10 |
2 |
8 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010033;response to organic substance
|
20 |
12 |
0 |
8 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0031214;biomineral tissue development
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035408;histone H3-T6 phosphorylation
|
11 |
7 |
0 |
7 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0034351;negative regulation of glial cell apoptotic process
|
8 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0043627;response to estrogen
|
11 |
6 |
1 |
3 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0016579;protein deubiquitination
|
25 |
15 |
2 |
6 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042743;hydrogen peroxide metabolic process
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046456;icosanoid biosynthetic process
|
32 |
17 |
2 |
7 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0050878;regulation of body fluid levels
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007613;memory
|
35 |
11 |
1 |
11 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0001889;liver development
|
20 |
6 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045787;positive regulation of cell cycle
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015711;organic anion transport
|
37 |
16 |
1 |
9 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045931;positive regulation of mitotic cell cycle
|
44 |
20 |
2 |
15 |
0 |
3 |
BP |
GO:0008283;cell proliferation |
GO:0048146;positive regulation of fibroblast proliferation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0042981;regulation of apoptotic process
|
9 |
4 |
0 |
3 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0043697;cell dedifferentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071392;cellular response to estradiol stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0048149;behavioral response to ethanol
|
19 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0003014;renal system process
|
6 |
3 |
1 |
3 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0071383;cellular response to steroid hormone stimulus
|
39 |
12 |
1 |
14 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0038194;thyroid-stimulating hormone signaling pathway
|
57 |
17 |
1 |
20 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010894;negative regulation of steroid biosynthetic process
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038183;bile acid signaling pathway
|
472 |
205 |
6 |
122 |
0 |
11 |
BP |
Unclassified; |
GO:1904504;positive regulation of lipophagy
|
7 |
4 |
0 |
3 |
0 |
1 |
BP |
GO:0051179;localization |
GO:2001257;regulation of cation channel activity
|
1 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042572;retinol metabolic process
|
12 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019228;neuronal action potential
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0086010;membrane depolarization during action potential
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0035725;sodium ion transmembrane transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0034765;regulation of ion transmembrane transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048546;digestive tract morphogenesis
|
33 |
11 |
4 |
9 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0051000;positive regulation of nitric-oxide synthase activity
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045821;positive regulation of glycolytic process
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000573;positive regulation of DNA biosynthetic process
|
8 |
8 |
3 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway
|
2 |
1 |
1 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0015758;glucose transport
|
29 |
11 |
2 |
7 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0032229;negative regulation of synaptic transmission, GABAergic
|
3 |
3 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0052652;cyclic purine nucleotide metabolic process
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045986;negative regulation of smooth muscle contraction
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042135;neurotransmitter catabolic process
|
31 |
11 |
0 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0014063;negative regulation of serotonin secretion
|
30 |
10 |
0 |
9 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0060065;uterus development
|
16 |
3 |
1 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042180;cellular ketone metabolic process
|
4 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001817;regulation of cytokine production
|
3 |
3 |
1 |
2 |
0 |
1 |
BP |
GO:0002376;immune system process |
GO:0045321;leukocyte activation
|
4 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071356;cellular response to tumor necrosis factor
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1900182;positive regulation of protein localization to nucleus
|
10 |
6 |
1 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006974;cellular response to DNA damage stimulus
|
9 |
6 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0055015;ventricular cardiac muscle cell development
|
20 |
6 |
2 |
5 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0006874;cellular calcium ion homeostasis
|
19 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0001662;behavioral fear response
|
14 |
4 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0099566;regulation of postsynaptic cytosolic calcium ion concentration
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015718;monocarboxylic acid transport
|
3 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0035094;response to nicotine
|
11 |
11 |
4 |
4 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0065009;regulation of molecular function
|
6 |
4 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0001932;regulation of protein phosphorylation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032909;regulation of transforming growth factor beta2 production
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042417;dopamine metabolic process
|
13 |
9 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0008217;regulation of blood pressure
|
28 |
14 |
0 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0051259;protein oligomerization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000733;DNA strand renaturation
|
48 |
19 |
1 |
14 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0044255;cellular lipid metabolic process
|
8 |
7 |
0 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032094;response to food
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007095;mitotic G2 DNA damage checkpoint
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0001525;angiogenesis
|
4 |
4 |
1 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007249;I-kappaB kinase/NF-kappaB signaling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0009968;negative regulation of signal transduction
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021885;forebrain cell migration
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032467;positive regulation of cytokinesis
|
17 |
4 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0014075;response to amine
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0046960;sensitization
|
16 |
7 |
0 |
7 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0060292;long term synaptic depression
|
14 |
5 |
0 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019226;transmission of nerve impulse
|
13 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042053;regulation of dopamine metabolic process
|
16 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045187;regulation of circadian sleep/wake cycle, sleep
|
18 |
6 |
0 |
7 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007617;mating behavior
|
13 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0050482;arachidonic acid secretion
|
24 |
12 |
0 |
9 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032880;regulation of protein localization
|
15 |
7 |
2 |
5 |
0 |
0 |
BP |
GO:0040007;growth |
GO:0040008;regulation of growth
|
11 |
6 |
1 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0035356;cellular triglyceride homeostasis
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007628;adult walking behavior
|
51 |
16 |
1 |
18 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:2001025;positive regulation of response to drug
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0046903;secretion
|
7 |
4 |
2 |
0 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0045777;positive regulation of blood pressure
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0046888;negative regulation of hormone secretion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051896;regulation of protein kinase B signaling
|
11 |
2 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0033604;negative regulation of catecholamine secretion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009056;catabolic process
|
8 |
5 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071241;cellular response to inorganic substance
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060745;mammary gland branching involved in pregnancy
|
5 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043524;negative regulation of neuron apoptotic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010821;regulation of mitochondrion organization
|
6 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043085;positive regulation of catalytic activity
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0048013;ephrin receptor signaling pathway
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901529;positive regulation of anion channel activity
|
6 |
3 |
1 |
1 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0034502;protein localization to chromosome
|
4 |
3 |
3 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0006855;drug transmembrane transport
|
13 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015872;dopamine transport
|
8 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015697;quaternary ammonium group transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007077;mitotic nuclear envelope disassembly
|
25 |
10 |
2 |
9 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0043279;response to alkaloid
|
42 |
11 |
1 |
9 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0072488;ammonium transmembrane transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050996;positive regulation of lipid catabolic process
|
5 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015874;norepinephrine transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901374;acetate ester transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051051;negative regulation of transport
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071103;DNA conformation change
|
3 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0046618;drug export
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0038111;interleukin-7-mediated signaling pathway
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway
|
12 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0048639;positive regulation of developmental growth
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032868;response to insulin
|
69 |
31 |
0 |
19 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0000902;cell morphogenesis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0030098;lymphocyte differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0048609;multicellular organismal reproductive process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043618;regulation of transcription from RNA polymerase II promoter in response to stress
|
5 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0051384;response to glucocorticoid
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0044774;mitotic DNA integrity checkpoint
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0007268;chemical synaptic transmission
|
6 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0048511;rhythmic process |
GO:0007623;circadian rhythm
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:2001023;regulation of response to drug
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009411;response to UV
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006004;fucose metabolic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019637;organophosphate metabolic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006081;cellular aldehyde metabolic process
|
3 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007188;adenylate cyclase-modulating G-protein coupled receptor signaling pathway
|
5 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0030003;cellular cation homeostasis
|
25 |
13 |
0 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0031324;negative regulation of cellular metabolic process
|
44 |
16 |
0 |
14 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0010906;regulation of glucose metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0010891;negative regulation of sequestering of triglyceride
|
131 |
66 |
3 |
31 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0010887;negative regulation of cholesterol storage
|
120 |
60 |
3 |
30 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0010871;negative regulation of receptor biosynthetic process
|
118 |
60 |
3 |
30 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0019933;cAMP-mediated signaling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0001997;positive regulation of the force of heart contraction by epinephrine-norepinephrine
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0001996;positive regulation of heart rate by epinephrine-norepinephrine
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050873;brown fat cell differentiation
|
2 |
2 |
2 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0042596;fear response
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0042391;regulation of membrane potential
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0035095;behavioral response to nicotine
|
6 |
6 |
2 |
2 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0014832;urinary bladder smooth muscle contraction
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0001558;regulation of cell growth
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051260;protein homooligomerization
|
2 |
1 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060523;prostate epithelial cord elongation
|
6 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060688;regulation of morphogenesis of a branching structure
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0033031;positive regulation of neutrophil apoptotic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045833;negative regulation of lipid metabolic process
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0022610;biological adhesion |
GO:0030155;regulation of cell adhesion
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006260;DNA replication
|
12 |
7 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001038;regulation of cellular response to drug
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0006979;response to oxidative stress
|
9 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1903531;negative regulation of secretion by cell
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015908;fatty acid transport
|
169 |
82 |
4 |
46 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0051282;regulation of sequestering of calcium ion
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090330;regulation of platelet aggregation
|
6 |
3 |
0 |
3 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0046627;negative regulation of insulin receptor signaling pathway
|
46 |
12 |
0 |
10 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0050861;positive regulation of B cell receptor signaling pathway
|
2 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0051973;positive regulation of telomerase activity
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006725;cellular aromatic compound metabolic process
|
13 |
8 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032270;positive regulation of cellular protein metabolic process
|
11 |
5 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045944;positive regulation of transcription from RNA polymerase II promoter
|
5 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0008360;regulation of cell shape
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0043304;regulation of mast cell degranulation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007258;JUN phosphorylation
|
9 |
1 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000077;DNA damage checkpoint
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0046330;positive regulation of JNK cascade
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070873;regulation of glycogen metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038095;Fc-epsilon receptor signaling pathway
|
16 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0045087;innate immune response
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010389;regulation of G2/M transition of mitotic cell cycle
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048666;neuron development
|
8 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0043536;positive regulation of blood vessel endothelial cell migration
|
2 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0010518;positive regulation of phospholipase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032091;negative regulation of protein binding
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0089700;protein kinase D signaling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:2001184;positive regulation of interleukin-12 secretion
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2000251;positive regulation of actin cytoskeleton reorganization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0000185;activation of MAPKKK activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010628;positive regulation of gene expression
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031023;microtubule organizing center organization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:0044089;positive regulation of cellular component biogenesis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038033;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051301;cell division
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0002076;osteoblast development
|
5 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0030878;thyroid gland development
|
4 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0031000;response to caffeine
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006811;ion transport
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007093;mitotic cell cycle checkpoint
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0014038;regulation of Schwann cell differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0097176;epoxide metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901386;negative regulation of voltage-gated calcium channel activity
|
17 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0051586;positive regulation of dopamine uptake involved in synaptic transmission
|
21 |
9 |
0 |
6 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032415;regulation of sodium:proton antiporter activity
|
21 |
9 |
0 |
6 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021984;adenohypophysis development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035404;histone-serine phosphorylation
|
14 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019932;second-messenger-mediated signaling
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090170;regulation of Golgi inheritance
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060440;trachea formation
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060020;Bergmann glial cell differentiation
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903800;positive regulation of production of miRNAs involved in gene silencing by miRNA
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043410;positive regulation of MAPK cascade
|
21 |
12 |
1 |
6 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043405;regulation of MAP kinase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0001963;synaptic transmission, dopaminergic
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050927;positive regulation of positive chemotaxis
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010641;positive regulation of platelet-derived growth factor receptor signaling pathway
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0007267;cell-cell signaling
|
3 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033590;response to cobalamin
|
8 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000630;positive regulation of miRNA metabolic process
|
23 |
7 |
0 |
8 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045075;regulation of interleukin-12 biosynthetic process
|
15 |
5 |
0 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071316;cellular response to nicotine
|
21 |
6 |
0 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902532;negative regulation of intracellular signal transduction
|
11 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0045646;regulation of erythrocyte differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007254;JNK cascade
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090400;stress-induced premature senescence
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019896;axonal transport of mitochondrion
|
47 |
16 |
0 |
15 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0032930;positive regulation of superoxide anion generation
|
33 |
9 |
0 |
11 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis
|
3 |
2 |
0 |
1 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0051092;positive regulation of NF-kappaB transcription factor activity
|
10 |
3 |
0 |
3 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0042542;response to hydrogen peroxide
|
13 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0048545;response to steroid hormone
|
3 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051926;negative regulation of calcium ion transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019371;cyclooxygenase pathway
|
14 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006198;cAMP catabolic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071479;cellular response to ionizing radiation
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002683;negative regulation of immune system process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0001934;positive regulation of protein phosphorylation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0043542;endothelial cell migration
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0031667;response to nutrient levels
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060687;regulation of branching involved in prostate gland morphogenesis
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0097421;liver regeneration
|
30 |
8 |
2 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway
|
32 |
11 |
2 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0008210;estrogen metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032147;activation of protein kinase activity
|
9 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007417;central nervous system development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051248;negative regulation of protein metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031635;adenylate cyclase-inhibiting opioid receptor signaling pathway
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071242;cellular response to ammonium ion
|
3 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032769;negative regulation of monooxygenase activity
|
16 |
7 |
1 |
6 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0032956;regulation of actin cytoskeleton organization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050730;regulation of peptidyl-tyrosine phosphorylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0061041;regulation of wound healing
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043488;regulation of mRNA stability
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019825;oxygen binding
|
2225 |
1050 |
82 |
626 |
1 |
38 |
MF |
GO:0003824;catalytic activity |
GO:0070330;aromatase activity
|
1941 |
923 |
74 |
541 |
1 |
37 |
MF |
GO:0005488;binding |
GO:0051879;Hsp90 protein binding
|
619 |
309 |
26 |
201 |
0 |
13 |
MF |
GO:0005488;binding |
GO:0005506;iron ion binding
|
1613 |
757 |
57 |
460 |
1 |
26 |
MF |
GO:0003824;catalytic activity |
GO:0004089;carbonate dehydratase activity
|
2724 |
1341 |
98 |
791 |
3 |
67 |
MF |
GO:0005488;binding |
GO:0020037;heme binding
|
1845 |
873 |
61 |
526 |
1 |
31 |
MF |
GO:0005488;binding |
GO:0005524;ATP binding
|
547 |
263 |
21 |
158 |
0 |
16 |
MF |
Unclassified; |
GO:0004716;signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
290 |
149 |
12 |
93 |
0 |
5 |
MF |
GO:0005488;binding |
GO:0044877;macromolecular complex binding
|
163 |
85 |
7 |
51 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
106 |
55 |
2 |
38 |
0 |
3 |
MF |
GO:0005488;binding |
GO:0019838;growth factor binding
|
220 |
119 |
9 |
79 |
0 |
4 |
MF |
GO:0104005;hijacked molecular function |
GO:0001618;virus receptor activity
|
218 |
100 |
7 |
72 |
0 |
6 |
MF |
GO:0005488;binding |
GO:0043548;phosphatidylinositol 3-kinase binding
|
172 |
94 |
9 |
63 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0043559;insulin binding
|
284 |
144 |
11 |
90 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0042562;hormone binding
|
248 |
137 |
11 |
91 |
0 |
5 |
MF |
GO:0060089;molecular transducer activity |
GO:0005021;vascular endothelial growth factor-activated receptor activity
|
545 |
242 |
8 |
150 |
0 |
10 |
MF |
GO:0060089;molecular transducer activity |
GO:0004714;transmembrane receptor protein tyrosine kinase activity
|
156 |
70 |
5 |
36 |
0 |
3 |
MF |
GO:0005488;binding |
GO:0005504;fatty acid binding
|
279 |
171 |
27 |
101 |
1 |
14 |
MF |
GO:0003824;catalytic activity |
GO:0008395;steroid hydroxylase activity
|
673 |
319 |
20 |
184 |
0 |
5 |
MF |
GO:0003824;catalytic activity |
GO:0003845;11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity
|
22 |
10 |
1 |
5 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0034875;caffeine oxidase activity
|
870 |
424 |
37 |
231 |
0 |
7 |
MF |
GO:0003824;catalytic activity |
GO:0009055;electron transfer activity
|
194 |
84 |
3 |
52 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0000166;nucleotide binding
|
95 |
43 |
2 |
20 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0009378;four-way junction helicase activity
|
129 |
63 |
3 |
42 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0051378;serotonin binding
|
113 |
61 |
10 |
35 |
0 |
5 |
MF |
GO:0060089;molecular transducer activity |
GO:0004993;G-protein coupled serotonin receptor activity
|
112 |
60 |
10 |
35 |
0 |
5 |
MF |
Unclassified; |
GO:0004872;receptor activity
|
456 |
236 |
29 |
144 |
0 |
12 |
MF |
GO:0005488;binding |
GO:0051379;epinephrine binding
|
193 |
91 |
9 |
52 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0051380;norepinephrine binding
|
26 |
14 |
4 |
7 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0071886;1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding
|
53 |
31 |
8 |
14 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0001965;G-protein alpha-subunit binding
|
18 |
6 |
0 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0004937;alpha1-adrenergic receptor activity
|
20 |
8 |
1 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0004938;alpha2-adrenergic receptor activity
|
298 |
136 |
13 |
70 |
0 |
7 |
MF |
GO:0060089;molecular transducer activity |
GO:0004939;beta-adrenergic receptor activity
|
20 |
8 |
2 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0004985;opioid receptor activity
|
23 |
8 |
1 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0001591;dopamine neurotransmitter receptor activity, coupled via Gi/Go
|
46 |
20 |
1 |
12 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0005496;steroid binding
|
351 |
173 |
13 |
111 |
1 |
7 |
MF |
GO:0060089;molecular transducer activity |
GO:0038052;RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
281 |
147 |
13 |
87 |
1 |
6 |
MF |
GO:0005488;binding |
GO:0034056;estrogen response element binding
|
240 |
129 |
13 |
75 |
1 |
5 |
MF |
GO:0098772;molecular function regulator |
GO:0030235;nitric-oxide synthase regulator activity
|
100 |
46 |
2 |
33 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0035174;histone serine kinase activity
|
71 |
27 |
2 |
13 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0008270;zinc ion binding
|
1402 |
705 |
61 |
411 |
2 |
34 |
MF |
GO:0003824;catalytic activity |
GO:0004222;metalloendopeptidase activity
|
90 |
42 |
3 |
25 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0017171;serine hydrolase activity
|
21 |
7 |
0 |
6 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0001609;G-protein coupled adenosine receptor activity
|
228 |
136 |
10 |
80 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0042802;identical protein binding
|
229 |
146 |
11 |
83 |
0 |
4 |
MF |
Unclassified; |
GO:0032403;protein complex binding
|
240 |
118 |
11 |
70 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0004064;arylesterase activity
|
601 |
292 |
23 |
168 |
0 |
9 |
MF |
GO:0005488;binding |
GO:0046914;transition metal ion binding
|
132 |
61 |
2 |
39 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0031072;heat shock protein binding
|
49 |
32 |
0 |
19 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0032451;demethylase activity
|
186 |
81 |
1 |
57 |
0 |
4 |
MF |
GO:0060089;molecular transducer activity |
GO:0004952;dopamine neurotransmitter receptor activity
|
12 |
6 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0070576;vitamin D 24-hydroxylase activity
|
300 |
146 |
15 |
85 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0101020;estrogen 16-alpha-hydroxylase activity
|
261 |
126 |
14 |
74 |
0 |
3 |
MF |
Unclassified; |
GO:0005057;signal transducer activity, downstream of receptor
|
30 |
10 |
1 |
4 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0005518;collagen binding
|
23 |
17 |
4 |
7 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0047750;cholestenol delta-isomerase activity
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004949;cannabinoid receptor activity
|
146 |
59 |
3 |
41 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0043621;protein self-association
|
41 |
19 |
1 |
10 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043560;insulin receptor substrate binding
|
130 |
63 |
7 |
35 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004666;prostaglandin-endoperoxide synthase activity
|
142 |
69 |
7 |
39 |
0 |
3 |
MF |
GO:0003824;catalytic activity |
GO:0047977;hepoxilin-epoxide hydrolase activity
|
288 |
177 |
22 |
110 |
0 |
12 |
MF |
GO:0003824;catalytic activity |
GO:0004052;arachidonate 12-lipoxygenase activity
|
273 |
169 |
22 |
101 |
0 |
11 |
MF |
GO:0003824;catalytic activity |
GO:0051120;hepoxilin A3 synthase activity
|
274 |
170 |
22 |
102 |
0 |
10 |
MF |
GO:0005215;transporter activity |
GO:0005412;glucose:sodium symporter activity
|
51 |
23 |
4 |
12 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0097371;MDM2/MDM4 family protein binding
|
44 |
26 |
3 |
14 |
1 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0004712;protein serine/threonine/tyrosine kinase activity
|
40 |
13 |
1 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004713;protein tyrosine kinase activity
|
6 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004674;protein serine/threonine kinase activity
|
10 |
8 |
1 |
3 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0004879;nuclear receptor activity
|
247 |
121 |
10 |
69 |
0 |
4 |
MF |
GO:0060089;molecular transducer activity |
GO:0038023;signaling receptor activity
|
46 |
25 |
4 |
13 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0008144;drug binding
|
38 |
25 |
1 |
10 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0001223;transcription coactivator binding
|
28 |
17 |
6 |
7 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0046982;protein heterodimerization activity
|
17 |
13 |
4 |
8 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0003682;chromatin binding
|
42 |
15 |
4 |
10 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0042803;protein homodimerization activity
|
67 |
31 |
6 |
21 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0019902;phosphatase binding
|
41 |
26 |
4 |
10 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0031690;adrenergic receptor binding
|
84 |
43 |
5 |
27 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0045550;geranylgeranyl reductase activity
|
56 |
25 |
0 |
22 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0047718;indanol dehydrogenase activity
|
49 |
19 |
0 |
18 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0003690;double-stranded DNA binding
|
53 |
28 |
3 |
21 |
0 |
3 |
MF |
GO:0060089;molecular transducer activity |
GO:0003707;steroid hormone receptor activity
|
215 |
100 |
5 |
61 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0051425;PTB domain binding
|
30 |
13 |
0 |
11 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004715;non-membrane spanning protein tyrosine kinase activity
|
20 |
10 |
0 |
6 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0005088;Ras guanyl-nucleotide exchange factor activity
|
7 |
4 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004683;calmodulin-dependent protein kinase activity
|
15 |
8 |
0 |
4 |
0 |
0 |
MF |
Unclassified; |
GO:0004704;NF-kappaB-inducing kinase activity
|
4 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors
|
86 |
41 |
5 |
15 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004033;aldo-keto reductase (NADP) activity
|
22 |
13 |
0 |
6 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0046934;phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
21 |
15 |
3 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003990;acetylcholinesterase activity
|
124 |
64 |
2 |
35 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0035173;histone kinase activity
|
37 |
16 |
2 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008389;coumarin 7-hydroxylase activity
|
59 |
32 |
1 |
20 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
28 |
23 |
2 |
9 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004969;histamine receptor activity
|
19 |
12 |
4 |
9 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035257;nuclear hormone receptor binding
|
3 |
3 |
1 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0035005;1-phosphatidylinositol-4-phosphate 3-kinase activity
|
23 |
11 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031994;insulin-like growth factor I binding
|
20 |
10 |
0 |
6 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0016907;G-protein coupled acetylcholine receptor activity
|
29 |
24 |
5 |
8 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004435;phosphatidylinositol phospholipase C activity
|
27 |
22 |
5 |
7 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0043140;ATP-dependent 3'-5' DNA helicase activity
|
80 |
33 |
1 |
26 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0003684;damaged DNA binding
|
21 |
11 |
0 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0036094;small molecule binding
|
29 |
11 |
1 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019903;protein phosphatase binding
|
18 |
10 |
1 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005102;receptor binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0004707;MAP kinase activity
|
6 |
4 |
0 |
3 |
0 |
0 |
MF |
Unclassified; |
GO:0004708;MAP kinase kinase activity
|
8 |
5 |
0 |
4 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001784;phosphotyrosine residue binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0008134;transcription factor binding
|
68 |
27 |
1 |
17 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0004887;thyroid hormone receptor activity
|
174 |
39 |
1 |
40 |
0 |
4 |
MF |
GO:0005215;transporter activity |
GO:0005234;extracellularly glutamate-gated ion channel activity
|
36 |
23 |
3 |
15 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0015277;kainate selective glutamate receptor activity
|
36 |
23 |
3 |
15 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0004971;AMPA glutamate receptor activity
|
36 |
22 |
3 |
14 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0005497;androgen binding
|
38 |
16 |
2 |
12 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0005330;dopamine:sodium symporter activity
|
38 |
17 |
4 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016614;oxidoreductase activity, acting on CH-OH group of donors
|
23 |
10 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043546;molybdopterin cofactor binding
|
11 |
5 |
0 |
3 |
0 |
0 |
MF |
Unclassified; |
GO:0003906;DNA-(apurinic or apyrimidinic site) lyase activity
|
17 |
7 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016491;oxidoreductase activity
|
32 |
24 |
0 |
19 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035240;dopamine binding
|
40 |
21 |
0 |
14 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003824;catalytic activity
|
45 |
22 |
0 |
10 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0008381;mechanosensitive ion channel activity
|
33 |
17 |
0 |
9 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042610;CD8 receptor binding
|
25 |
15 |
3 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042608;T cell receptor binding
|
19 |
10 |
1 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042609;CD4 receptor binding
|
20 |
11 |
1 |
4 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008353;RNA polymerase II carboxy-terminal domain kinase activity
|
11 |
8 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051525;NFAT protein binding
|
5 |
4 |
1 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000978;RNA polymerase II proximal promoter sequence-specific DNA binding
|
44 |
10 |
1 |
11 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0050473;arachidonate 15-lipoxygenase activity
|
96 |
48 |
4 |
29 |
0 |
3 |
MF |
GO:0140110;transcription regulator activity |
GO:0001077;transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding
|
14 |
5 |
1 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005178;integrin binding
|
20 |
5 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0032450;maltose alpha-glucosidase activity
|
43 |
19 |
3 |
12 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004558;alpha-1,4-glucosidase activity
|
25 |
12 |
3 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001221;transcription cofactor binding
|
9 |
4 |
2 |
3 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0008392;arachidonic acid epoxygenase activity
|
129 |
60 |
4 |
36 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004698;calcium-dependent protein kinase C activity
|
13 |
9 |
0 |
8 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0035403;histone kinase activity (H3-T6 specific)
|
16 |
12 |
0 |
11 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004699;calcium-independent protein kinase C activity
|
18 |
10 |
0 |
8 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004629;phospholipase C activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0004871;signal transducer activity
|
63 |
33 |
2 |
23 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0008502;melatonin receptor activity
|
6 |
6 |
2 |
1 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035259;glucocorticoid receptor binding
|
5 |
3 |
1 |
2 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004996;thyroid-stimulating hormone receptor activity
|
105 |
40 |
3 |
35 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0038181;bile acid receptor activity
|
532 |
204 |
7 |
133 |
0 |
12 |
MF |
GO:0003824;catalytic activity |
GO:0001758;retinal dehydrogenase activity
|
95 |
39 |
1 |
27 |
0 |
2 |
MF |
GO:0005215;transporter activity |
GO:0005248;voltage-gated sodium channel activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005244;voltage-gated ion channel activity
|
3 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047374;methylumbelliferyl-acetate deacetylase activity
|
36 |
19 |
0 |
6 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0099583;neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015347;sodium-independent organic anion transmembrane transporter activity
|
151 |
51 |
3 |
41 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0036310;annealing helicase activity
|
23 |
5 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031625;ubiquitin protein ligase binding
|
13 |
3 |
0 |
4 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0001588;dopamine neurotransmitter receptor activity, coupled via Gs
|
18 |
9 |
0 |
7 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019900;kinase binding
|
9 |
3 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042826;histone deacetylase binding
|
12 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0098782;mechanosensitived potassium channel activity
|
17 |
9 |
0 |
6 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0003705;transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding
|
32 |
10 |
1 |
8 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0005329;dopamine transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015651;quaternary ammonium group transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015307;drug:proton antiporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005333;norepinephrine transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005277;acetylcholine transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0008513;secondary active organic cation transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051434;BH3 domain binding
|
24 |
15 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019904;protein domain specific binding
|
8 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004497;monooxygenase activity
|
31 |
15 |
0 |
9 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004560;alpha-L-fucosidase activity
|
2 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050543;icosatetraenoic acid binding
|
76 |
38 |
3 |
19 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0031694;alpha-2A adrenergic receptor binding
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004693;cyclin-dependent protein serine/threonine kinase activity
|
7 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001047;core promoter binding
|
6 |
2 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0050321;tau-protein kinase activity
|
2 |
2 |
0 |
2 |
0 |
0 |
MF |
Unclassified; |
GO:0004705;JUN kinase activity
|
9 |
1 |
0 |
3 |
0 |
0 |
MF |
Unclassified; |
GO:0008349;MAP kinase kinase kinase kinase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019901;protein kinase binding
|
38 |
9 |
2 |
6 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0016787;hydrolase activity
|
4 |
2 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004697;protein kinase C activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003677;DNA binding
|
6 |
2 |
0 |
3 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005030;neurotrophin receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000287;magnesium ion binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005007;fibroblast growth factor-activated receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004301;epoxide hydrolase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0008289;lipid binding
|
8 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0051213;dioxygenase activity
|
22 |
10 |
2 |
6 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0032795;heterotrimeric G-protein binding
|
6 |
6 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047555;3',5'-cyclic-GMP phosphodiesterase activity
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051721;protein phosphatase 2A binding
|
121 |
40 |
3 |
26 |
0 |
6 |
MF |
GO:0005488;binding |
GO:0042923;neuropeptide binding
|
2 |
2 |
1 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0016323;basolateral plasma membrane
|
681 |
309 |
29 |
202 |
0 |
12 |
CC |
GO:0044464;cell part |
GO:0048471;perinuclear region of cytoplasm
|
180 |
78 |
2 |
53 |
0 |
5 |
CC |
GO:0043226;organelle |
GO:0005654;nucleoplasm
|
223 |
113 |
5 |
68 |
0 |
2 |
CC |
GO:0016020;membrane |
GO:0045121;membrane raft
|
172 |
80 |
4 |
60 |
0 |
5 |
CC |
GO:0016020;membrane |
GO:0005789;endoplasmic reticulum membrane
|
393 |
164 |
13 |
102 |
0 |
2 |
CC |
GO:0043226;organelle |
GO:0043231;intracellular membrane-bounded organelle
|
125 |
57 |
2 |
35 |
0 |
1 |
CC |
GO:0044425;membrane part |
GO:0005887;integral component of plasma membrane
|
286 |
131 |
15 |
85 |
0 |
9 |
CC |
GO:0032991;macromolecular complex |
GO:0043235;receptor complex
|
91 |
42 |
5 |
32 |
0 |
4 |
CC |
GO:0044464;cell part |
GO:0042995;cell projection
|
65 |
35 |
2 |
20 |
0 |
2 |
CC |
GO:0032991;macromolecular complex |
GO:0032133;chromosome passenger complex
|
76 |
32 |
4 |
13 |
0 |
2 |
CC |
GO:0044464;cell part |
GO:0099056;integral component of presynaptic membrane
|
225 |
135 |
10 |
79 |
0 |
4 |
CC |
GO:0016020;membrane |
GO:0005901;caveola
|
95 |
45 |
4 |
31 |
0 |
2 |
CC |
GO:0043226;organelle |
GO:0005634;nucleus
|
28 |
14 |
1 |
12 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0005876;spindle microtubule
|
262 |
99 |
2 |
57 |
0 |
5 |
CC |
GO:0044464;cell part |
GO:0030424;axon
|
49 |
29 |
2 |
14 |
0 |
3 |
CC |
GO:0016020;membrane |
GO:0005886;plasma membrane
|
209 |
91 |
11 |
52 |
0 |
5 |
CC |
GO:0016020;membrane |
GO:0016020;membrane
|
125 |
61 |
3 |
40 |
0 |
8 |
CC |
GO:0044464;cell part |
GO:0005739;mitochondrion
|
55 |
28 |
0 |
22 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0051233;spindle midzone
|
12 |
5 |
0 |
2 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0030673;axolemma
|
177 |
78 |
5 |
52 |
0 |
7 |
CC |
GO:0044456;synapse part |
GO:0099055;integral component of postsynaptic membrane
|
69 |
40 |
0 |
22 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005829;cytosol
|
94 |
49 |
0 |
30 |
0 |
3 |
CC |
GO:0044464;cell part |
GO:0031234;extrinsic component of cytoplasmic side of plasma membrane
|
56 |
25 |
0 |
19 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0005737;cytoplasm
|
43 |
20 |
1 |
11 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0032838;plasma membrane bounded cell projection cytoplasm
|
255 |
110 |
10 |
69 |
0 |
6 |
CC |
GO:0044464;cell part |
GO:0043204;perikaryon
|
63 |
40 |
3 |
21 |
0 |
1 |
CC |
GO:0044456;synapse part |
GO:0043679;axon terminus
|
25 |
20 |
3 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0014069;postsynaptic density
|
7 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0045211;postsynaptic membrane
|
54 |
37 |
5 |
15 |
0 |
2 |
CC |
GO:0044456;synapse part |
GO:0042734;presynaptic membrane
|
6 |
4 |
0 |
2 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0008328;ionotropic glutamate receptor complex
|
6 |
3 |
0 |
2 |
0 |
0 |
CC |
GO:0045202;synapse |
GO:0032279;asymmetric synapse
|
18 |
13 |
1 |
3 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0001518;voltage-gated sodium channel complex
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0033268;node of Ranvier
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0048786;presynaptic active zone
|
2 |
2 |
1 |
1 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0031090;organelle membrane
|
237 |
100 |
5 |
59 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0097730;non-motile cilium
|
29 |
13 |
0 |
10 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0060170;ciliary membrane
|
17 |
7 |
0 |
6 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0032839;dendrite cytoplasm
|
12 |
7 |
1 |
4 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0032983;kainate selective glutamate receptor complex
|
17 |
9 |
0 |
6 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0043195;terminal bouton
|
18 |
10 |
0 |
7 |
0 |
0 |
CC |
GO:0030054;cell junction |
GO:0030054;cell junction
|
3 |
3 |
1 |
1 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0070062;extracellular exosome
|
61 |
20 |
1 |
18 |
0 |
3 |
CC |
Unclassified; |
GO:0043234;protein complex
|
28 |
11 |
0 |
7 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005813;centrosome
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005641;nuclear envelope lumen
|
72 |
30 |
0 |
20 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0009986;cell surface
|
23 |
12 |
1 |
8 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0033256;I-kappaB/NF-kappaB complex
|
43 |
19 |
2 |
13 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043005;neuron projection
|
31 |
14 |
1 |
8 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005884;actin filament
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
Unclassified; |
GO:0005902;microvillus
|
9 |
5 |
1 |
1 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0097060;synaptic membrane
|
23 |
5 |
0 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0042470;melanosome
|
72 |
28 |
1 |
24 |
0 |
5 |
CC |
GO:0044464;cell part |
GO:0005783;endoplasmic reticulum
|
51 |
11 |
2 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
|
4 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035335;peptidyl-tyrosine dephosphorylation
|
305 |
130 |
3 |
73 |
0 |
8 |
BP |
GO:0009987;cellular process |
GO:1902202;regulation of hepatocyte growth factor receptor signaling pathway
|
407 |
161 |
4 |
95 |
0 |
8 |
BP |
GO:0065007;biological regulation |
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process
|
149 |
57 |
6 |
43 |
0 |
5 |
BP |
GO:0032501;multicellular organismal process |
GO:0019233;sensory perception of pain
|
53 |
19 |
0 |
14 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0006940;regulation of smooth muscle contraction
|
65 |
21 |
2 |
14 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046890;regulation of lipid biosynthetic process
|
11 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009750;response to fructose
|
32 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901216;positive regulation of neuron death
|
61 |
21 |
0 |
16 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0006281;DNA repair
|
3 |
2 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0051534;negative regulation of NFAT protein import into nucleus
|
4 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006631;fatty acid metabolic process
|
32 |
16 |
0 |
8 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060338;regulation of type I interferon-mediated signaling pathway
|
54 |
16 |
0 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0033277;abortive mitotic cell cycle
|
28 |
11 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1902894;negative regulation of pri-miRNA transcription from RNA polymerase II promoter
|
54 |
29 |
2 |
18 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0001523;retinoid metabolic process
|
19 |
6 |
0 |
8 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0002237;response to molecule of bacterial origin
|
12 |
5 |
0 |
7 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0046626;regulation of insulin receptor signaling pathway
|
263 |
111 |
3 |
68 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:1903897;regulation of PERK-mediated unfolded protein response
|
180 |
77 |
1 |
47 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0009755;hormone-mediated signaling pathway
|
13 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032431;activation of phospholipase A2 activity
|
9 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
|
7 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031145;anaphase-promoting complex-dependent catabolic process
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0034501;protein localization to kinetochore
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0051583;dopamine uptake involved in synaptic transmission
|
32 |
11 |
2 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006066;alcohol metabolic process
|
12 |
5 |
2 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042133;neurotransmitter metabolic process
|
39 |
10 |
0 |
10 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042359;vitamin D metabolic process
|
9 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046483;heterocycle metabolic process
|
12 |
7 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007584;response to nutrient
|
15 |
7 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015860;purine nucleoside transmembrane transport
|
39 |
27 |
0 |
14 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1904823;purine nucleobase transmembrane transport
|
74 |
42 |
5 |
22 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015855;pyrimidine nucleobase transport
|
74 |
42 |
5 |
22 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009165;nucleotide biosynthetic process
|
7 |
6 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060736;prostate gland growth
|
32 |
9 |
0 |
6 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0030217;T cell differentiation
|
6 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0055088;lipid homeostasis
|
7 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0032024;positive regulation of insulin secretion
|
7 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050872;white fat cell differentiation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010745;negative regulation of macrophage derived foam cell differentiation
|
8 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046321;positive regulation of fatty acid oxidation
|
7 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032966;negative regulation of collagen biosynthetic process
|
7 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050968;detection of chemical stimulus involved in sensory perception of pain
|
21 |
10 |
1 |
6 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0050955;thermoception
|
22 |
11 |
1 |
7 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0047484;regulation of response to osmotic stress
|
25 |
11 |
0 |
6 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage
|
6 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006089;lactate metabolic process
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006284;base-excision repair
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0033004;negative regulation of mast cell activation
|
40 |
9 |
0 |
8 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045759;negative regulation of action potential
|
40 |
9 |
0 |
8 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0050796;regulation of insulin secretion
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001816;cytokine production
|
12 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0060032;notochord regression
|
32 |
8 |
1 |
9 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0007418;ventral midline development
|
32 |
8 |
1 |
9 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0021696;cerebellar cortex morphogenesis
|
31 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0007507;heart development
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0072531;pyrimidine-containing compound transmembrane transport
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050729;positive regulation of inflammatory response
|
4 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0048660;regulation of smooth muscle cell proliferation
|
25 |
10 |
0 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060548;negative regulation of cell death
|
35 |
9 |
1 |
10 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0002532;production of molecular mediator involved in inflammatory response
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0042632;cholesterol homeostasis
|
64 |
17 |
2 |
15 |
0 |
4 |
BP |
GO:0032501;multicellular organismal process |
GO:0014005;microglia development
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032640;tumor necrosis factor production
|
6 |
4 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042446;hormone biosynthetic process
|
19 |
11 |
0 |
6 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016311;dephosphorylation
|
50 |
19 |
0 |
11 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:1904357;negative regulation of telomere maintenance via telomere lengthening
|
21 |
13 |
2 |
9 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1904646;cellular response to amyloid-beta
|
7 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070212;protein poly-ADP-ribosylation
|
17 |
11 |
2 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001054;negative regulation of mesenchymal cell apoptotic process
|
14 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1900113;negative regulation of histone H3-K9 trimethylation
|
6 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0006820;anion transport
|
5 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0015812;gamma-aminobutyric acid transport
|
5 |
2 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0070544;histone H3-K36 demethylation
|
4 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0033169;histone H3-K9 demethylation
|
4 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0009966;regulation of signal transduction
|
3 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0050790;regulation of catalytic activity
|
6 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1904064;positive regulation of cation transmembrane transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0002028;regulation of sodium ion transport
|
17 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0031223;auditory behavior
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009299;mRNA transcription
|